Chief Executive Officer
Steven invented the patent pending KAREL technology during his PhD research in mechanical engineering at the University of Canterbury. He is a former IBM Blue Fern Fellow, a MacDiarmid Commercial Fellow and was selected as one of the 100 Leaders of Tomorrow at the 41st St.Gallen Symposium in 2011 in Switzerland. He earned his Engineering degree from the University of Canterbury. Steven was originally supposed to join the Stanford Genome Technology Center as a Visiting Scholar before he pivoted to focus full-time at Mekonos. He is currently a Visiting Scholar at UC Berkeley under the Global Founders Program.
Chief Scientific Officer
Anil did his postdoctoral fellowship under Michael Snyder at Stanford University working on genomics and personalized medicine. He received his Bachelor of Arts degree from UC Berkeley working with Gary Firestone treating endometrial cancer. Anil received his PhD in Biology from UC San Diego working with Steven Dowdy elucidating the mechanism of regulation of the retinoblastoma protein during cell cycle progression. In addition to his publications in top-tier journals such as Cell, Anil is also a accomplished musician.
Greg has fulfilled a distinguished business career spanning more than 40 years. His roles have primarily been in executive management, sales and business development, and then more latterly in corporate and professional governance. He has worked for Sun Microsystems and Silicon Graphics in NZ and Australia, with business forums in the USA and Asia and more recently with Sparkbox Venture Group, NZ’s leading early stage venture group. He has held posts on a number of key industry forums and received many international business awards. Greg has a passion for assisting and investing in disruptive technologies that address some of the world’s major challenges.
Vice President of Engineering
Mark is primarily involved with the fabrication research and development of our nanoneedle micro-chip technology at the Molecular Foundry of the Lawrence Berkeley National Laboratory (LBNL). With previous extensive experience in nanofabrication at CXRO (LBNL) and the SLAC National Accelerator Laboratory at Stanford University for x-ray optics applications under the direction of David Attwood and Anne Sakdinawat, he is able to push the commercial scale development of our chip technology in a big way. Mark graduated from UC Berkeley with a background in chemistry, self assembling nanomaterials, materials science, and engineering.
SCIENTIFIC ADVISORY BOARD
Irving L. Weissman, MD
Dr. Weissman directs the Institute for Stem Cell Biology and Regenerative Medicine, and the Ludwig Center for Cancer Stem Cell Research and Medicine both at Stanford University. As the first scientist to identify and isolate mammalian blood-forming stem cells in mice, Dr. Weissman is considered the father of hematopoiesis. His group has successfully defined the stages of development that occur between stems cells and mature progeny. He was elected to the National Academy of Sciences in 1989, American Association for the Advancement of Science, and American Academy of Arts and Sciences in 1990 and the Institute of Medicine in 2002. Among his recent awards are the Max Delbrück Medal in Molecular Medicine (2013), Lewis S. Rosenstiel Award (2009), Robert Koch Award, Berlin (2008) amongst others. He obtained his MD from Stanford University in 1965 after earning a BS from Montana State University in 1961.
Laura is the CEO of Translarity, a semiconductor test startup. Prior to joining Translarity, she was an Investment Director in Intel Capital, where she invested in semiconductor capital equipment, manufacturing robotics, new device, and software as a service (SaaS) companies. As a Corporate Venture Capital investor, Laura brought over $1B in strategic and financial value to Intel through her investments and was awarded Intel’s highest award, the Intel Achievement Award, for her contributions. Prior to Intel Capital, Laura served as a Supply Chain Program Manager in Intel’s Technology and Manufacturing Group (TMG). She was one of the key coordinators for Intel’s transition to the 300 mm wafer size in their factories, a project which delivered to cost targets, and added over 10 points of gross margin to Intel. Laura was the co-chairperson of the SEMATECH Metrology and Yield Management Advisory Group, and was part of the International Technology Roadmap for Semiconductors (ITRS) committee for yield management technology. Laura holds a PhD in Chemical Engineering from the University of California, Berkeley.
Aaron is a Principal at Novartis Venture Funds. He was previously a strategic project leader within the Trials of The Future team of Novartis Pharmaceuticals. In recent years, he has worked on technology strategy for clinical trial teams within Novartis. He has lead projects building upon these themes across multiple business units within Novartis, often by collaborations or investments in early-stage partner companies. Previously, he lead laboratory teams at Novartis, investigating the biological bases for drug toxicity. He was Group Head in the Investigative Toxicology organization. Aaron received his PhD from the University of Pennsylvania, his MD from Tufts University, and BA from Cornell University. He completed his postdoctoral training at the Karolinska University, Sweden.
Darren sits on Biotech and Devices committees of the Life Science Angels and screens the deals. Earlier to this, he led the IP legal team for the Life Science Group of Bio-Rad Laboratories. In his ten years at Bio-Rad, he led IP diligence and integration on dozens of deals, including Quantalife (digital PCR), GnuBIO (droplet-based sequencing), and Propel (cell sorter). He and his team also evaluated every new Bio-Rad invention, filed 400 new patent applications, had 250 US patents issue, and cleared 50+ new products for FTO. Before Bio-Rad, Darren was a patent litigator with Covington & Burling. Darren has a JD from Columbia Law School, MS in mechanical engineering from UC Berkeley, and BS in mechanical engineering from Cal Poly.
Louise, a pioneer of computer technologies for customer service, was a member of the first class of female freshman at Caltech. She founded and managed two venture capital based startups. Answer Systems was the first company in the internal help desk automation market. Broad Daylight, the second company, was among the very first to deliver SaaS CRM solutions to major organizations including Cisco, ATT, BellSouth, McDonalds, and Kodak. Louise has served on two Boards for the State of California Department of Consumer Affairs. She is currently a member of the Caltech Board of Trustees. In 1976, she was a finalist in the first selection of astronauts for the NASA Space Shuttle program. She earned her bachelor’s and master’s degrees in electrical engineering from CalTech.
Copyright (c)2016 Mekonos Limited Inc. All rights reserved.